NEW YORK (Reuters Health) - Low-dose aspirin is predominantly of value in reducing atherosclerotic events in patients with less advanced diabetes, Japanese researchers report in an April 22nd online paper in Diabetes Care.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.